Description: Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying on therapy, according to a new North American survey of ...
Tags: aprn bayer betaplus betaseron centers cnrn consortium copaxone healthcare inc. international ms mscn msn multiple nurses organization pharmaceuticals rebif sclerosis survey
Total views: 12